XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.3
REVENUE - Narrative (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Revenue and Concentration Risk [Line Items]          
Revenue recognized $ 8,600,000 $ 7,100,000 $ 17,300,000 $ 6,200,000  
Change in earnings per share (dollars per share) $ 0.09 $ 0.07 $ 0.19 $ 0.06  
Revenue recognized due to retroactive coverage change     $ 3,000,000.0    
Capitalized costs incurred to obtain or fulfill contract $ 0   $ 0    
Government Contracts Concentration Risk | Medicare | Revenues          
Revenue and Concentration Risk [Line Items]          
Concentration risk (percent) 11.00% 12.00% 11.00% 12.00%  
Customer concentration | Medicare | Accounts receivable          
Revenue and Concentration Risk [Line Items]          
Concentration risk (percent)     19.00%   12.00%